BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 5939140)

  • 1. Adverse effects of depolarising neuromuscular blocking agents. Incidence, prevention and management.
    Book WJ; Abel M; Eisenkraft JB
    Drug Saf; 1994 May; 10(5):331-49. PubMed ID: 8037887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled succinylcholine infusion in a patient receiving echothiophate eye drops.
    Donati F; Bevan DR
    Can Anaesth Soc J; 1981 Sep; 28(5):488-90. PubMed ID: 7284894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic side effects with eye drops.
    Alexander WD
    Br Med J (Clin Res Ed); 1981 Apr; 282(6273):1359. PubMed ID: 6786494
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduction in plasma cholinesterase levels after prolonged administration of echothiophate iodide eyedrops.
    Eilderton TE; Farmati O; Zsigmond EK
    Can Anaesth Soc J; 1968 May; 15(3):291-6. PubMed ID: 5658433
    [No Abstract]   [Full Text] [Related]  

  • 5. Ecothiopate iodide eye drops and prolonged response to suxamethonium.
    Pantuck EJ
    Br J Anaesth; 1966 May; 38(5):406-7. PubMed ID: 5939139
    [No Abstract]   [Full Text] [Related]  

  • 6. ECT, glaucoma, and prolonged apnea.
    Chessen DH; Geha DG; Salzman C
    Dis Nerv Syst; 1974 Apr; 35(4):152-3. PubMed ID: 17894110
    [No Abstract]   [Full Text] [Related]  

  • 7. Eye drops and apnea.
    Can Med Assoc J; 1983 Apr; 128(8):894. PubMed ID: 6831330
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of phospholine iodide eye drops on blood cholinesterase in glaucoma patients.
    Ben-Dor D; Weisenberg E
    Isr J Med Sci; 1966; 2(5):624-5. PubMed ID: 5970651
    [No Abstract]   [Full Text] [Related]  

  • 9. Cholinergic toxicity resulting from ocular instillation of echothiophate iodide eye drops.
    Manoguerra A; Whitney C; Clark RF; Anderson B; Turchen S
    J Toxicol Clin Toxicol; 1995; 33(5):463-5. PubMed ID: 7650771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged apnoea after suxamethonium injection associated with eye drops containing an anticholinesterase agent.
    Gesztes T
    Br J Anaesth; 1966 May; 38(5):408-9. PubMed ID: 5939140
    [No Abstract]   [Full Text] [Related]  

  • 11. [Side effects of anticholinesterase].
    Sawada A
    Ganka; 1967 Nov; 9(11):791-7. PubMed ID: 4876404
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic effects of eye drops.
    Davidson SI
    Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):487-95. PubMed ID: 4143267
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.